RxDoctor Payments Data

Tara Ralph, DO

Internal Medicine · Murfreesboro, TNNPI 1184048795

Payments from drug & device makers

$8,357in general payments, 2019–2025

Across 533 payments — averaging $15.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$1K
  • Astellas Pharma US Inc$843
  • Otsuka America Pharmaceutical, Inc.$587
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$444
  • Amgen$359
  • plus $3K from 34 others

What the payments were for

  • Food & beverage$8,327100%
  • Gifts$300%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,357 in reported general payments places this provider in the 90th percentile of 2,216 internal medicine providers in Tennessee.

See all internal medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$166,351
Medicare patients
336
Services billed
9,715

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide95$140,154
EliquisApixaban44$36,027
JanuviaSitagliptin Phosphate27$27,098
FarxigaDapagliflozin Propanediol22$25,761
JardianceEmpagliflozin15$24,111
MounjaroTirzepatide15$22,359
RybelsusSemaglutide15$21,100
MyrbetriqMirabegron11$11,211
Janumet XrSitagliptin Phos/Metformin Hcl15$10,467
Tresiba Flextouch U-100Insulin Degludec20$9,521
Breo ElliptaFluticasone/Vilanterol20$7,557
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$5,509
Bupropion XlBupropion Hcl66$5,438
SynthroidLevothyroxine Sodium77$5,392
ShingrixVaricella-Zoster Ge/As01b/Pf21$4,627

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,566$161,254110 claims
MerckJanuvia, Janumet Xr, Janumet$218$41,01954 claims
PfizerEliquis$267$36,02744 claims
AstraZenecaFarxiga$99$25,76122 claims
Boehringer IngelheimJardiance$277$24,11115 claims
Lilly USA, LLCMounjaro$341$22,35915 claims
GSKBreo Ellipta, Shingrix$340$12,18441 claims
Astellas Pharma US IncMyrbetriq$843$11,21111 claims
AbbVieSynthroid$1,191$5,39277 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$25$2,865372 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,216 internal medicine providers in Tennessee.

Other internal medicine in Murfreesboro

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →